GSK Pharma surges 11%, hits 52-week high on improved outlook

The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningful performance improvement.

GSK Pharma surges 11%, hits 52-week high on improved
outlook
The management expects this positive momentum to continue through the second half of the year driving the company towards the better end of a meaningful performance improvement.